These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 20524320)
1. Bortezomib as a rescue therapy for hyperacute and multi-drug resistant mixed acute rejection after kidney transplantation. Djamali A; Muth BL; Torrealba J; Bloom D; Miller KM; Lorentzen D; Sollinger HW; Pirsch JD; Mezrich JD Clin Transpl; 2009; ():485-90. PubMed ID: 20524320 [No Abstract] [Full Text] [Related]
2. Rescue therapy for early antibody mediated rejection with a proteasome inhibitor: a case report. Manitpisitkul W; Wilson N; Cooper M; Gurk-Turner C; Hurley H; Rasetto F; KuKuruga D; Barth RN; Philosophe B Clin Transpl; 2009; ():461-3. PubMed ID: 20524315 [No Abstract] [Full Text] [Related]
4. The role of proteasome inhibition with bortezomib in the treatment of antibody-mediated rejection after kidney-only or kidney-combined organ transplantation. Flechner SM; Fatica R; Askar M; Stephany BR; Poggio E; Koo A; Banning S; Chiesa-Vottero A; Srinivas T Transplantation; 2010 Dec; 90(12):1486-92. PubMed ID: 21042239 [TBL] [Abstract][Full Text] [Related]
5. Bortezomib rescue in refractory acute humoral rejection--report of a case. Shapiro R; Basu A; Zeevi A; Lunz J; Mapara M; Randhawa P; Morgan C; Tan HP; Sharma V Clin Transpl; 2009; ():431-2. PubMed ID: 20524310 [No Abstract] [Full Text] [Related]
6. Bortezomib as therapy for mixed humoral and cellular rejection: should it be first line? Lee I; Constantinescu S; Gillespie A; Swami A; Birkenbach M; Leech S; Silva P; Karachristos A; Daller JA; Sifontis NM Clin Transpl; 2009; ():425-9. PubMed ID: 20524309 [No Abstract] [Full Text] [Related]
7. Bortezomib in the treatment of antibody-mediated rejection--a report of 3 cases. Mai HL; Cesbron A; Brouard S; Blanchol G; Cantarovich D; Dantal J; Hourmant M; Lino M; Meurette A; Gosselin M; Abbadie O; Soulillou JP; Giral M Clin Transpl; 2009; ():361-8. PubMed ID: 20524299 [No Abstract] [Full Text] [Related]
10. Use of bortezomib for prevention and treatment of rejection in sensitized patients. Hartono C; Lubetzky M; Aull MJ; Saal S; Figueiro J; Kapur S; Dadhania D Clin Transpl; 2009; ():499-503. PubMed ID: 20524323 [TBL] [Abstract][Full Text] [Related]
11. Acute humoral rejection in a lung recipient: reversion with bortezomib. Neumann J; Tarrasconi H; Bortolotto A; Machuca T; Canabarro R; Sporleder H; Fernandes S; Schio S; Costa C; Camargo S; Sanchez L; Camargo J; Perin F; Felicetti J; Michelon T Transplantation; 2010 Jan; 89(1):125-6. PubMed ID: 20061929 [No Abstract] [Full Text] [Related]
12. Bortezomib for the treatment of de novo HLA antibody-related antibody mediated rejection. Al Meshari K Clin Transpl; 2009; ():385-6. PubMed ID: 20524302 [No Abstract] [Full Text] [Related]
13. Use of bortezomib for treatment of antibody medicated rejection in kidney transplant recipients--case report. Hamawi K; Heilman RL; Mazur MJ; Chakkera HA; Mulligan DC; Moss AA; Mekeel KL; Reddy KS Clin Transpl; 2009; ():407-14. PubMed ID: 20524306 [No Abstract] [Full Text] [Related]
14. Antihumoral rejection therapy by proteasome inhibitor bortezomib: a case series. Lachmann N; Schütz M; Budde K; Schönemann C; Waiser J Clin Transpl; 2009; ():351-8. PubMed ID: 20527073 [TBL] [Abstract][Full Text] [Related]
15. Bortezomib for acute humoral rejection in two repeat transplant recipients. Hardinger KL; Alford K; Murillo D Clin Transpl; 2009; ():479-83. PubMed ID: 20524319 [TBL] [Abstract][Full Text] [Related]
16. Bortezomib use in chronic antibody-mediated allograft dysfunction: a report of three cases. Cooper JE; Wiseman AC; Chan L Clin Transpl; 2009; ():455-9. PubMed ID: 20524314 [No Abstract] [Full Text] [Related]
17. Case presentations on two patients who received bortezomib for antibody mediated rejection at BIDMC. Pavlakis M Clin Transpl; 2009; ():343-5. PubMed ID: 20524296 [TBL] [Abstract][Full Text] [Related]
18. Successful treatment with bortezomib of a refractory humoral rejection of the intestine after multivisceral transplantation. Island ER; Gonzalez-Pinto IM; Tsai HL; Ruiz P; Tryphonopoulos P; Gonzalez ML; Solano JP; Rossique M; Selvaggi G; Tekin A; Smith LJ; Tzakis AG Clin Transpl; 2009; ():465-9. PubMed ID: 20524316 [TBL] [Abstract][Full Text] [Related]
19. OKT3 first-line treatment of acute rejection episodes following combined pancreas and kidney transplantation. Cantarovich D; Hourmant M; Dantal J; Giral M; Paineau J; Karam G; Soulillou JP Transplant Proc; 1994 Apr; 26(2):549. PubMed ID: 8171548 [No Abstract] [Full Text] [Related]
20. A summary of bortezomib use in transplantation across 29 centers. Everly MJ Clin Transpl; 2009; ():323-37. PubMed ID: 20524294 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]